Date Informed Consent Obtained (Date informed consent obtained)
CL Item
Does The Participant Have A Direct Bilirubin Level Of <=2.0 Mg/dl (Does the participant have a direct bilirubin level of <=2.0 mg/dL)
CL Item
Does The Participant Have A Histologic Diagnosis Of Burkitt's Lymphoma (bl) Or Atypical Burkitt's As Per Who Criteria (Does the participant have a histologic diagnosis of Burkitt's lymphoma (BL) or atypical Burkitt's as per WHO criteria)
CL Item
Does The Participant Have A Serum Creatinine <=1.5 Mg/dl (Does the participant have a serum creatinine <=1.5 mg/dL)
CL Item
Does The Participant Have Anc >=1000/ul And Platelets >=50,000ul (unless Disease-related) (Does the participant have ANC >=1000/uL and platelets >=50,000uL (unless disease-related))
CL Item
Does The Participant Have Ast (sgot) And Alt (sgpt) <=3 X The Upper Limit Of Normal (Does the participant have AST (SGOT) and ALT (SGPT) <=3 x the upper limit of normal)
CL Item
Does The Participant Have Measurable Or Nonmeasurable Tumor Parameter(s) (Does the participant have measurable or non-measurable tumor parameter(s))
CL Item
Does The Participant Have Normal Baseline Cardiac Function Based Upon Echocardiogram Or Multigated Acquisition (muga) Blood Pool Scan With An Ejection Fraction >=50% (Does the participant have normal baseline cardiac function based upon echocardiogram or multigated acquisition (MUGA) blood pool scan with an ejection fraction >=50%)
CL Item
If The Elevated Bilirubin Is Felt To Be Secondary To Antiretroviral Therapy, Is The Participant's Total Bilirubin <=3.5 Mg/dl Provided That The Direct Bilirubin Is Normal (If the elevated bilirubin is felt to be secondary to antiretroviral therapy, is the participant's total bilirubin <=3.5 mg/dL provided that the direct bilirubin is normal)
CL Item
If The Participant Is Female Who Is Premenopausal, Did She Have A Negative Pregnancy Test (If the participant is female who is premenopausal, did she have a negative pregnancy test)
CL Item
If The Participant Is Female, Is She Of Childbearing Age And Using An Acceptable Form Of Birth Control (If the participant is female, is she of childbearing age and using an acceptable form of birth control)
CL Item
If The Participant's Creatinine Is >1.5 Mg/dl, Is The Creatinine Clearance >=60 Ml/minute (If the participant's creatinine is >1.5 mg/dL, is the creatinine clearance >=60 mL/minute)
CL Item
Is The Participant (or Their Guardian) Capable Of Providing Informed Consent (Is the participant (or their guardian) capable of providing informed consent)
CL Item
Is The Participant Hiv Positive Documented By Enzyme-linked Immunosorbent Assay [elisa] And Western Blot, Or Measurable Hiv Viral Load (Is the participant HIV positive documented by enzyme-linked immunosorbent assay [ELISA] and Western Blot, or measurable HIV viral load)
CL Item
Karnofsky Performance Status (must Be >30%) (Karnofsky performance status (must be >30%))
CL Item
Participant's Age (in Years) (Participant's age (in years))
Does The Participant Have A History Of Any Malignancy For Which The Disease-free Interval Is <5 Years, Excluding Curatively Treated Cutaneous Basal Cell Or Squamous Cell Carcinoma And Carcinoma In Situ Of The Cervix Or Cutaneous Ks (Does the participant have a history of any malignancy for which the disease-free interval is <5 years, excluding curatively treated cutaneous basal cell or squamous cell carcinoma and carcinoma in situ of the cervix or cutaneous KS)
CL Item
Does The Participant Have Any Medical Illness Unrelated To Nhl, Which In The Opinion Of The Attending Physician And Principal Investigator (pi), Will Preclude Administration Of Chemotherapy Safely (Does the participant have any medical illness unrelated to NHL, which in the opinion of the attending physician and Principal Investigator (PI), will preclude administration of chemotherapy safely)
CL Item
Has The Participant Received Previous Therapy For Bl Or Atypical Bl Other Than Seven Consecutive Days Of Steroids (Has the participant received previous therapy for BL or atypical BL other than seven consecutive days of steroids)
CL Item
If The Participant Is Female, Is She Pregnant Or Breast-feeding (If the participant is female, is she pregnant or breast-feeding)
CL Item
If Yes, Will The Growth Factors Be Discontinued At Least 24 Hours Prior To Chemotherapy (If yes, will the growth factors be discontinued at least 24 hours prior to chemotherapy)
CL Item
Is The Participant Already Receiving Erythropoietin Or G-csf For Treatment Of Hiv-related Cytopenia (Is the participant already receiving erythropoietin or G-CSF for treatment of HIV-related cytopenia)